Hilsenbeck SG - Search Results

1

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.

Osborne CK, Jarman M, McCague R, Coronado EB, Hilsenbeck SG, Wakeling AE. Osborne CK, et al. Among authors: hilsenbeck sg. Cancer Chemother Pharmacol. 1994;34(2):89-95. doi: 10.1007/BF00685924. Cancer Chemother Pharmacol. 1994. PMID: 8194171

2

Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues.

McGuire SE, Hilsenbeck SG, Figueroa JA, Jackson JG, Yee D. McGuire SE, et al. Among authors: hilsenbeck sg. Cancer Lett. 1994 Feb 28;77(1):25-32. doi: 10.1016/0304-3835(94)90343-3. Cancer Lett. 1994. PMID: 7512885

3

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI. Osborne CK, et al. Among authors: hilsenbeck sg. J Natl Cancer Inst. 1995 May 17;87(10):746-50. doi: 10.1093/jnci/87.10.746. J Natl Cancer Inst. 1995. PMID: 7563152

4

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM. Isola JJ, et al. Among authors: hilsenbeck sg. Am J Pathol. 1995 Oct;147(4):905-11. Am J Pathol. 1995. PMID: 7573366 Free PMC article.

5

Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.

Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D. Figueroa JA, et al. Among authors: hilsenbeck sg. J Cell Physiol. 1993 Nov;157(2):229-36. doi: 10.1002/jcp.1041570204. J Cell Physiol. 1993. PMID: 7693722

6

Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.

Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK. Reddy KB, et al. Among authors: hilsenbeck sg. Cell Growth Differ. 1994 Dec;5(12):1275-82. Cell Growth Differ. 1994. PMID: 7696176

7

Prognostic factors: rationale and methods of analysis and integration.

Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M, Osborne CK. Clark GM, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1994;32(1):105-12. doi: 10.1007/BF00666211. Breast Cancer Res Treat. 1994. PMID: 7819579 Review.

8

Heat shock proteins and drug resistance.

Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Fuqua SA, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Breast Cancer Res Treat. 1994. PMID: 7819588 Review.

9

Investigation of taxol as a potential radiation sensitizer.

Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD. Choy H, et al. Cancer. 1993 Jun 1;71(11):3774-8. doi: 10.1002/1097-0142(19930601)71:11<3774::aid-cncr2820711147>3.0.co;2-0. Cancer. 1993. PMID: 8098270

10

The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.

Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. Oesterreich S, et al. Among authors: hilsenbeck sg. Cancer Res. 1993 Oct 1;53(19):4443-8. Cancer Res. 1993. PMID: 8402609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page